Acticor Biotech
Master degree of Biotechnology Engineering with a focus on R&D and Health, Kristell Lebozec has a 2 years experience in academic laboratories (Institut Gustave Roussy and Centre de Recherche des Cordeliers) and in the industry (DNA Therapeutics and I-Stem). She joined Acticor Biotech in 2015 and was in charge of selecting ACT017 expression system and of the functional characterization of product. She is now managing the pharmaceutical and non-clinical development.
This person is not in any offices
Acticor Biotech
Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes.